Press release
Cardiac Biomarker Testing Market Worth USD 5.09B in 2025
Cardiac Biomarker Testing Market: Global Overview, Trends, and Future Outlook
The Cardiac Biomarker Testing Market has become a cornerstone of modern cardiovascular diagnostics, enabling faster, more accurate detection of heart-related conditions and significantly improving patient outcomes. As cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, early diagnosis and timely intervention are critical. Cardiac biomarkers-measurable substances released into the blood when the heart is damaged or stressed-play a pivotal role in diagnosing myocardial infarction, acute coronary syndrome, heart failure, and other cardiac events.
In 2025, the global cardiac biomarker testing market was valued at USD 5.09 billion, driven by the rising prevalence of cardiovascular diseases, aging populations, and growing awareness of preventive cardiac care. The market is expected to expand at a CAGR of 8.80% from 2026 to 2035, reaching approximately USD 11.83 billion by 2035.
Understanding Cardiac Biomarker Testing
Cardiac biomarker testing involves analyzing blood samples to detect specific proteins or enzymes released during cardiac injury or stress. These tests help clinicians:
Rapidly confirm or rule out myocardial infarction
Assess severity and prognosis of heart failure
Guide treatment decisions and monitor therapy response
Commonly used biomarkers include troponins, CK-MB, myoglobin, and natriuretic peptides, each offering unique diagnostic value depending on the clinical scenario.
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/cardiac-biomarker-testing-market/requestsample.
Market Overview and Scope
The Cardiac Biomarker Testing Market encompasses a wide range of diagnostic technologies, testing platforms, and clinical applications used across hospitals, laboratories, and point-of-care settings. Its growth is closely tied to:
Increasing global burden of heart disease
Technological advancements in diagnostics
Expansion of point-of-care testing (POCT)
Rising healthcare spending in emerging economies
As healthcare systems shift toward value-based care, early and accurate cardiac diagnostics are becoming indispensable.
Key Market Growth Drivers
Rising Prevalence of Cardiovascular Diseases
Heart disease continues to account for a significant share of global deaths. Sedentary lifestyles, unhealthy diets, obesity, diabetes, and hypertension are major contributors, fueling demand for reliable cardiac diagnostic tools.
Growing Aging Population
Older adults are at higher risk of cardiac conditions, increasing the need for routine and emergency cardiac biomarker testing.
Advancements in Diagnostic Technologies
Innovations such as high-sensitivity troponin assays, multiplex testing, and automated analyzers have improved diagnostic accuracy and reduced turnaround time.
Expansion of Point-of-Care Testing
POCT allows rapid decision-making in emergency departments, ambulances, and remote settings, significantly improving clinical outcomes.
Increasing Awareness and Preventive Screening
Public health initiatives and improved access to healthcare services are encouraging earlier testing and diagnosis.
Emerging Trends in the Cardiac Biomarker Testing Market
Shift Toward High-Sensitivity Biomarkers
High-sensitivity troponin assays are becoming the gold standard for early myocardial infarction detection, enabling diagnosis within hours of symptom onset.
Integration with Digital Health
Cardiac diagnostics are increasingly integrated with electronic health records (EHRs), AI-driven decision support, and remote monitoring systems.
Multiplex and Panel-Based Testing
Clinicians are adopting panels that measure multiple biomarkers simultaneously, providing a more comprehensive cardiac risk profile.
Growth in Emerging Markets
Asia Pacific and Latin America are witnessing rapid adoption due to improving healthcare infrastructure and rising CVD prevalence.
Market Segmentation Analysis
By Testing Type
Point of Care Testing (POCT)
POCT is one of the fastest-growing segments due to its ability to deliver rapid results at the patient's bedside. It is widely used in emergency departments and ambulatory settings.
Laboratory Testing
Laboratory-based testing remains dominant, offering high accuracy, automation, and the ability to process large sample volumes.
By Technology
Immunoassay
Immunoassays dominate the market, particularly for troponin and BNP testing, due to their high sensitivity and specificity.
Clinical Chemistry
Used for enzyme-based biomarkers such as CK-MB and myoglobin, clinical chemistry platforms are widely available in hospital labs.
Molecular Diagnostics
An emerging segment focused on genetic and molecular markers associated with cardiovascular risk.
Others
Includes biosensors and novel assay technologies under development.
By Biomarker Type
Creatine Kinase (CK-MB): Traditionally used for myocardial infarction detection
Troponins: Gold standard biomarkers for acute myocardial injury
Myoglobin: Early marker of muscle injury, often used in combination tests
Natriuretic Peptides (BNP and NT-proBNP): Essential for heart failure diagnosis and prognosis
Ischemia Modified Albumins: Useful for detecting ischemic events
Other Biomarkers: Include emerging markers for inflammation and oxidative stress
Troponins and natriuretic peptides collectively account for the largest market share.
By Application
Myocardial Infarction
The largest application segment, driven by the need for rapid diagnosis and intervention.
Congestive Heart Failure
BNP and NT-proBNP testing is critical for diagnosis, risk stratification, and monitoring.
Acute Coronary Syndrome
Biomarker testing supports early detection and differentiation of ACS subtypes.
Atherosclerosis
Used alongside imaging and lipid profiling to assess cardiovascular risk.
Other Applications
Include perioperative risk assessment and research use.
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/cardiac-biomarker-testing-market.
By End User
Hospitals and Clinics: Primary users due to emergency and inpatient care needs
Diagnostic Laboratories: High-volume testing and reference diagnostics
Ambulatory Surgical Centers: Growing adoption for perioperative cardiac risk assessment
Research Institutes: Focused on biomarker discovery and validation
Others: Includes specialty cardiac centers
Regional Analysis
North America
North America leads the market, supported by advanced healthcare infrastructure, high CVD prevalence, and rapid adoption of innovative diagnostic technologies.
Europe
Europe follows closely, driven by strong regulatory frameworks, aging populations, and widespread use of high-sensitivity assays.
Asia Pacific
The fastest-growing region, fueled by rising cardiovascular disease burden, expanding healthcare access, and government initiatives to improve diagnostics.
Latin America
Market growth is supported by improving healthcare systems and increasing awareness of heart disease.
Middle East and Africa
While still developing, this region presents long-term growth opportunities as diagnostic infrastructure expands.
Competitive Landscape
The Cardiac Biomarker Testing Market is highly competitive, with global diagnostics leaders and regional players focusing on innovation, portfolio expansion, and geographic reach.
Key Companies Covered
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG
Beckman Coulter, Inc. (Danaher Corporation)
bioMérieux SA
Ortho Clinical Diagnostics
Becton, Dickinson and Company (BD)
Thermo Fisher Scientific Inc.
Randox Laboratories Ltd.
Bio-Rad Laboratories, Inc.
Singulex Inc.
LSI Medience Corporation
Trivitron Healthcare
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Werfen and others
Strategic partnerships, assay innovation, and expansion into emerging markets are key competitive strategies.
Challenges and Market Constraints
Despite strong growth prospects, the market faces several challenges:
High cost of advanced diagnostic platforms
Reimbursement variability across regions
Limited access in low-resource settings
Need for skilled personnel and quality control
Addressing these challenges is essential to ensure equitable access to cardiac diagnostics.
Future Outlook: 2026-2035
The Cardiac Biomarker Testing Market is poised for robust growth over the next decade. Key developments expected include:
Wider adoption of high-sensitivity and multiplex assays
Greater use of AI and data analytics in cardiac diagnostics
Expansion of POCT in remote and emergency settings
Increased focus on preventive cardiology and population screening
As cardiovascular diseases continue to rise, cardiac biomarker testing will remain a critical pillar of global healthcare systems.
Discover More Reports
Active Pharmaceutical Ingredients (API) Market - https://bit.ly/4i5ab2V.
Cough Syrup Market - https://bit.ly/49XwNAg.
North America Hemoglobinopathies Market- https://www.linkedin.com/pulse/north-america-hemoglobinopathies-market-insights-2035-roshan-kumar-rtnuc.
North America Clinical Trials Market - https://www.linkedin.com/pulse/north-america-clinical-trials-market-size-outlook-2035-roshan-kumar-eipjc.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Biomarker Testing Market Worth USD 5.09B in 2025 here
News-ID: 4329464 • Views: …
More Releases from Expert Market Research
Pegfilgrastim Biosimilars Market to Reach USD 1.22M by 2035
Can Pegfilgrastim Biosimilars Redefine Supportive Cancer Care Worldwide?
Pegfilgrastim Biosimilars Market: Global Overview, Trends, and Future Outlook
The Pegfilgrastim Biosimilars Market is emerging as a critical component of modern oncology care, driven by the rising global burden of cancer-particularly leukaemia-and the need to reduce the cost of biologic therapies. Pegfilgrastim, a long-acting granulocyte colony-stimulating factor (G-CSF), plays a vital role in preventing chemotherapy-induced neutropenia, a potentially life-threatening complication that increases infection risk…
Hypovolemia Epidemiology Forecast Report 2026-2035
Is Hypovolemia Emerging as a Silent Driver of Preventable Mortality Worldwide?
Hypovolemia Epidemiology Forecast: Global Burden, Trends, and Outlook (2026-2035)
Hypovolemia remains one of the most critical yet often underrecognized medical conditions contributing to acute morbidity and mortality worldwide. Characterized by a significant reduction in circulating blood or plasma volume, hypovolemia can rapidly progress to hypovolemic shock, multi-organ failure, and death if not identified and treated promptly. The Hypovolemia Epidemiology Forecast highlights…
Express Delivery Market Size, Growth and Forecast (2026-2035)
The express delivery market plays a crucial role in the modern logistics and e-commerce industries, offering fast and reliable shipping services that help businesses meet tight deadlines and provide customers with near-instant gratification. As consumer demand for faster delivery times continues to rise, express delivery services have become indispensable to industries ranging from retail and healthcare to manufacturing and technology. With its ability to ensure quick and efficient delivery of…
Bronchial Spasm Epidemiology Forecast Report 2026-2035
What Does the Bronchial Spasm Epidemiology Forecast Reveal for 2026-2035?
Bronchial Spasm Epidemiology Forecast: Global Trends, Demographics, and Future Outlook (2026-2035)
Bronchial spasm-commonly referred to as bronchospasm-is a critical respiratory event marked by sudden narrowing of the airways due to contraction of bronchial smooth muscles. Closely associated with asthma, chronic obstructive pulmonary disease (COPD), allergic reactions, and post-infectious respiratory conditions, bronchial spasm represents a growing public health concern worldwide.
The Bronchial Spasm Epidemiology…
More Releases for Testing
Global Testing Market Size - By Product Type(Terpene Profiling Testing,Heavy Met …
Market Overview and Report Coverage
testing refers to the scientific analysis and evaluation of products to ensure their safety, potency, and compliance with regulatory standards. This process typically involves testing for profiles, contaminants, pesticides, heavy metals, and microbial residues. As becomes increasingly legalized for medicinal and recreational use across various regions, the demand for reliable testing services is growing, ensuring consumers receive high-quality…
Sterility Testing Market, Sterility Testing Market Analysis, Sterility Testing M …
"According to the research report, the global synthetic biology market was valued at USD 13.07 billion in 2022 and is expected to reach USD 71.51 billion by 2032, to grow at a CAGR of 18.5% during the forecast period."
Request Our Free Sample Report for Synthetic Biology Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/synthetic-biology-market/request-for-sample
Report Overview
Polaris Market Research, a leading global market research and consulting company, has recently published its latest report…
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study…
Test Automation Market | latest automation testing tools, automation testing too …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Test Automation Market “
The “Test Automation Market” report provides analysis of the global test automation market for the period 2015–2025, wherein the years from 2017 to 2025 is the forecast period and 2016 is considered as the base year. The report precisely…
Molecular Diagnostics Market Application On Infectious Disease Testing, Cardiova …
Worldwide Market Reports recently released “Global Molecular Diagnostics Market Research Report 2017” that centers around the latest developing trends and technologies in the Molecular Diagnostics Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022.
During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executives and other…
Test Automation Market Quadruples by 2023; with a ~ 15.34 % of Whooping CAGR | C …
New Market Research Reports Title "Test Automation Market 2018" Has Been Added to Crystal Market Research Report database.
Test Automation Market - Competitive Insights:
The leading players in the market are Cognizant Corporation, IBM, Hewlett-Packard, Capgemini, Tata Consultancy Services and Infosys. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Test…
